Indefinite Delivery Contract SPE2DB24D9134
Award Date
1/23/24
Last Date to Order
12/31/25
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The single-award contract has a potential value up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. This includes drugs and products such as flumazenil injection, prednisone...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has a potential value of up to $5,999,999 and a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will deliver a variety of pharmaceutical and medical products on a firm fixed-price basis,...
The Defense Logistics Agency has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical and medical products to support military treatment facilities worldwide. The contract has a potential value of up to $499,999,999 and a period of performance through December 2025. Under this IDC, DMS Pharmaceutical Group will deliver task orders for a variety of pharmaceutical items, including flumazenil injection,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support military medical facilities worldwide. The IDC, valued up to $499,999,999, allows DLA to issue firm fixed-price delivery orders for common medications like antibiotics and cardiovascular drugs, as well as specialized...
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award indefinite delivery contract worth up to $499,999,999 from the Defense Logistics Agency (DLA). The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Key categories of goods to be delivered include prescription drugs,...
DMS Pharmaceutical Group Inc., a for-profit woman-owned small business, was awarded a single-award indefinite delivery contract (IDC) by the Defense Logistics Agency (DLA) valued up to $4,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The contract covers a diverse...
DMS Pharmaceutical Group Inc. has been awarded an indefinite delivery contract by the Defense Logistics Agency to provide pharmaceutical supplies and medical products. The contract has a potential value of up to $5 million and a period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will supply various pharmaceutical items and medical supplies to support military treatment facilities worldwide. Some of the key products to be delivered include atropine,...
The Defense Logistics Agency (DLA), a logistics combat support agency within the Department of Defense, awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health...
The indefinite delivery contract SPE2DX15D9700 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award contract has a ceiling value of $4,999,999.00 and runs through November 12, 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health...